Evidence map›Paper›PMID 25585328›Full record

ArticleJAMA2015

Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.

Javaid Iqbal, Ophira Ginsburg, Paula A Rochon, Ping Sun, Steven A Narod

Erratum issued Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in JAMA, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT04248998 (Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemotherapy and a Diet Mimicking FASTing Plus/Minus Metformin in the Preoperative Setting), which is not on this map. Cited by 378 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
378citing papers in PubMed, 2 pooled it
23.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04248998 phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemotherapy and a Diet Mimicking FASTing Plus/Minus Metformin in the Preoperative Setting: the BREAKFAST Trial

TypeinterventionalSponsorFondazione IRCCS Istituto Nazionale dei Tumori, MilanoRan2020 to 2024Enrolled30ConditionsTriple-negative Breast CancerArmsFasting-mimicking diet, Metformin, Preoperative chemotherapy
3 · Its place in the literature

Who cites it

378 citing papers in PubMed, 2 syntheses or guidelines pooled it, 609 citations in OpenAlex.

  1. Racial Differences in Breast Cancer Survival Between Black and White Women According to Tumor Subtype: A Systematic Review and Meta-Analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Observational
  6. Review
  7. Examining the Role of the Social Vulnerability Index in the Association between Race/Ethnicity and Breast Cancer Outcomes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Immigration and Social Factors, Tumor Stage, and Risk of Contralateral Breast Cancer in Asian American and Hispanic Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  12. Article
  13. Outcomes of Breast Cancer Patients by Race and Ethnicity.Breast care (Basel, Switzerland) · 2026
    Article
  14. Article
  15. Article
  16. Association between Participant Characteristics and Breast Parenchymal Texture Variation among Postmenopausal Women.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Research Priorities and Future Directions in Cardio-Oncology.Current treatment options in oncology · 2026
    Review

318 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Javaid IqbalWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Ophira GinsburgWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada2Faculty of Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario.
Paula A RochonWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Ping SunWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada.
Steven A NarodWomen's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada3Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
Women's College Hospital · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

importanceWomen with early-stage breast cancers are expected to have excellent survival rates. It is important to identify factors that predict diagnosis of early-stage breast cancers.

objectiveTo determine the proportion of breast cancers that were identified at an early stage (stage I) in different racial/ethnic groups and whether ethnic differences may be better explained by early detection or by intrinsic biological differences in tumor aggressiveness. DESIGN, SETTING, AND

participantsObservational study of women diagnosed with invasive breast cancer from 2004 to 2011 who were identified in the Surveillance, Epidemiology, and End Results (SEER) 18 registries database (N = 452,215). For each of 8 racial/ethnic groups, biological aggressiveness (triple-negative cancers, lymph node metastases, and distant metastases) of small-sized tumors of 2.0 cm or less was estimated. The odds ratio (OR) for being diagnosed at stage I compared with a later stage and the hazard ratio (HR) for death from stage I breast cancer by racial/ethnic group were determined. The date of final follow-up was December 31, 2011. MAIN OUTCOMES AND MEASURES: Breast cancer stage at diagnosis and 7-year breast cancer-specific survival, adjusted for age at diagnosis, income, and estrogen receptor status.

resultsOf 373,563 women with invasive breast cancer, 268,675 (71.9%) were non-Hispanic white; 34,928 (9.4%), Hispanic white; 38,751 (10.4%), black; 25,211 (6.7%), Asian; and 5998 (1.6%), other ethnicities. Mean follow-up time was 40.6 months (median, 38 months). Compared with non-Hispanic white women diagnosed with stage I breast cancer (50.8%), Japanese women (56.1%) were more likely to be diagnosed (OR, 1.23 [95% CI, 1.15-1.31], P < .001) and black women (37.0%) were less likely to be diagnosed (OR, 0.65 [95% CI, 0.64-0.67], P < .001). Actuarial risk of death from stage I breast cancer at 7 years was higher among black women (6.2%) than non-Hispanic white women (3.0%) (HR, 1.57 [95% CI, 1.40-1.75]; P < .001), and lower among South Asian women (1.7%) (HR, 0.48 [95% CI, 0.20-1.15]; P = .10). Black women were more likely to die of breast cancer with small-sized tumors (9.0%) than non-Hispanic white women (4.6%) (HR, 1.96 [95% CI, 1.82-2.12]; P < .001); the difference remained after adjustment for income and estrogen receptor status (HR, 1.56 [95% CI, 1.45-1.69]; P < .001). CONCLUSIONS AND RELEVANCE: Among US women diagnosed with invasive breast cancer, the likelihood of diagnosis at an early stage, and survival after stage I diagnosis, varied by race and ethnicity. Much of the difference could be statistically accounted for by intrinsic biological differences such as lymph node metastasis, distant metastasis, and triple-negative behavior of tumors.

Indexed as

Neoplasm StagingAgedAsianBlack or African AmericanBlack PeopleBreast NeoplasmsFemaleFollow-Up StudiesHispanic or LatinoHumansLymphatic MetastasisMiddle AgedNative Hawaiian or Pacific IslanderNeoplasm InvasivenessRegistriesSEER Program

Identifiers

PMID25585328
OpenAlexW2067428007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.